Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome.
Tinguely M, Jenni B, Knights A, Lopes B, Korol D, Rousson V, Curioni Fontecedro A, Cogliatti SB, Bittermann AG, Schmid U, Dommann-Scherrer C, Maurer R, Renner C, Probst-Hensch NM, Moch H, Knuth A, Zippelius A. Tinguely M, et al. Cancer Sci. 2008 Apr;99(4):720-5. doi: 10.1111/j.1349-7006.2008.00738.x. Epub 2008 Feb 27. Cancer Sci. 2008. PMID: 18307538 Free article.
[Identification of tumor antigens: strategies and perspectives].
Zippelius A, Knights A, Tinguely M, Jäger D, Renner C, Knuth A. Zippelius A, et al. Dtsch Med Wochenschr. 2006 Aug 18;131(33):1809-12. doi: 10.1055/s-2006-949159. Dtsch Med Wochenschr. 2006. PMID: 16902905 Review. German. No abstract available.
MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma.
Curioni-Fontecedro A, Knights AJ, Tinguely M, Nuber N, Schneider C, Thomson CW, von Boehmer L, Bossart W, Pahlich S, Gehring H, Moch H, Renner C, Knuth A, Zippelius A. Curioni-Fontecedro A, et al. Among authors: knights aj. Leukemia. 2008 Aug;22(8):1646-8. doi: 10.1038/leu.2008.43. Epub 2008 Mar 6. Leukemia. 2008. PMID: 18323799 No abstract available.
HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides.
Mathieu MG, Knights AJ, Pawelec G, Riley CL, Wernet D, Lemonnier FA, Straten PT, Mueller L, Rees RC, McArdle SE. Mathieu MG, et al. Among authors: knights aj. Cancer Immunol Immunother. 2007 Dec;56(12):1885-95. doi: 10.1007/s00262-007-0331-2. Epub 2007 May 9. Cancer Immunol Immunother. 2007. PMID: 17487488 Free PMC article.
56 results